Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity

Abstract Background Schistosomiasis is a devastating parasitic disease. The mainstay of schistosomiasis control is by praziquantel treatment. The study aimed to determine benefits of annual chemotherapy of schistosomiasis on development of protective immunity in school children in a selected endemic...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Tawanda J. Chisango, Bongiwe Ndlovu, Arthur Vengesai, Agness Farai Nhidza, Edson P. Sibanda, Danai Zhou, Francisca Mutapi, Takafira Mduluza
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMC 2019-03-01
סדרה:	BMC Infectious Diseases
נושאים:	Praziquantel Schistosomiasis MDA Treatment Antibodies Immunity
גישה מקוונת:	http://link.springer.com/article/10.1186/s12879-019-3811-z
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!